comparemela.com
Latest Breaking News On - Approval timeline - Page 1 : comparemela.com
Immutep : Corporate Presentation -March 26, 2024 at 08:12 am EDT
Forward-Looking Statements The purpose of the presentation is to provide an update of the business of Immutep Limited ACN 009 237 889 . These slides have been.
China
Immutep-limited
Nasdaq
Novartis
First-in-class-lead
Nature-reviews-drug-discovery
Checkpoint-discovery
Approval-timeline
Chief-scientific-officer
Checkpoint-inhibitors
Asthma-reports
vimarsana © 2020. All Rights Reserved.